AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

HeartSciences Inc.

$3.39 +$0.25 (+7.96%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$3.51
Day Range
$3.31$3.69
Year Range
$1.63$4.35
Market Cap
7.32M
AVG Volume
2.3M
Trailing/Forward PE
-0.86/-
PEG ratio
0.03
Dividend Yield
-
Next Earnings Date
2026-12-10
Primary Exchange
NASDAQUS
Revenue (USD)
05K10K15K20K20222023202420252026
HSCS Revenue (USD) by year
PeriodRevenue (USD)
20264.32K
20254.35K
202418.6K
20235.15K
202214.37K
Net Income (USD)
-10M-7.5M-5M-2.5M020222023202420252026
HSCS Net Income (USD) by year
PeriodNet Income (USD)
2026-9.14M
2025-8.77M
2024-6.61M
2023-6.35M
2022-4.83M
Operating Income (USD)
-10M-7.5M-5M-2.5M020222023202420252026
HSCS Operating Income (USD) by year
PeriodOperating Income (USD)
2026-8.41M
2025-8.35M
2024-6.31M
2023-6.11M
2022-4.71M
EBITDA (USD)
-10M-7.5M-5M-2.5M020222023202420252026
HSCS EBITDA (USD) by year
PeriodEBITDA (USD)
2026-8.41M
2025-8.14M
2024-6.16M
2023-6.08M
2022-4.43M
Cash Flows (USD)
-15M-10M-5M020222023202420252026
HSCS Cash Flows (USD) by year
PeriodCash Flows (USD)
2026-7.47M
2025-7.44M
2024-6.2M
2023-13.03M
2022-3.65M
EPS (USD)
-150-100-50020222023202420252026
HSCS EPS (USD) by year
PeriodEPS (USD)
2026-3.92
2025-9.36
2024-35
2023-85.74
2022-147.67
Expenses (USD)
05M10M15MR&DSG&ACapex20222023202420252026
HSCS Expenses (USD) by year
PeriodExpenses (USD)
202644.45K
20258.29M
20246.46M
202313.35M
20224.69M
Cash & Debt (USD)
0500M1B1.5B2BCashLong Term DebtShort Term Debt20222023202420252026
HSCS Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20261.66B
20251.1M
20245.81M
20231.66M
2022918.26K
Debt ratios
-20020406020252026
HSCS Debt ratios by year
PeriodDebt ratios
202657.4
2025-0.08
Margins
-3000%-2000%-1000%0%20222023202420252026
HSCS Margins by year
PeriodMargins
2026-2982.1%
2025-2118.8%
2024-82.65%
2023-476.91%
2022-139.73%
Return on Capital
-6000%-4000%-2000%0%2000%20222023202420252026
HSCS Return on Capital by year
PeriodReturn on Capital
2026-4044%
2025-4272.16%
2024-90.27%
2023-2756.06%
202279.73%
Shares Outstanding
01M2M3M4M20222023202420252026
HSCS Shares Outstanding by year
PeriodShares Outstanding
20263.16M
20251.11M
2024676.6K
2023101.18K
202233.24K
Book Value Per Share (USD)
-200-150-100-5005020222023202420252026
HSCS Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20260.07
20250.18
202410.81
20232.28
2022-182.19
Total Assets (USD)
02.5M5M7.5M10M20222023202420252026
HSCS Total Assets (USD) by year
PeriodTotal Assets (USD)
20265.26M
20254.22M
20249.5M
20233.29M
20222.09M
Employee Count
05101520222023202420252026
HSCS Employee Count by year
PeriodEmployee Count
202614
202515
202415
202312
202212
Free Cash Flow Yield
-400%-300%-200%-100%0%med -206.73%Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
HSCS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Jun 26-96.79%
Jun 26-127.06%
Jun 26-129.88%
Jun 26-120.51%
May 26-139.99%
May 26-118.08%
May 26-129.17%
May 26-121.14%
May 26-117.48%
Apr 26-114.04%
Apr 26-108.74%
Apr 26-112.4%
Apr 26-101.65%
Mar 26-103.91%
Mar 26-91.68%
Mar 26-105.49%
Mar 26-102.7%
Feb 26-97.18%
Feb 26-96.48%
Feb 26-90.37%
Feb 26-90.68%
Jan 26-83.94%
Jan 26-78.59%
Jan 26-84.72%
Jan 26-82.66%
Jan 26-86.34%
Dec 25-95.13%
Dec 25-114.88%
Dec 25-221.96%
Dec 25-211.98%
Nov 25-211.19%
Nov 25-239.82%
Nov 25-184.36%
Nov 25-216.85%
Oct 25-185.57%
Oct 25-172.03%
Oct 25-169.97%
Oct 25-162.17%
Oct 25-152.97%
Sep 25-155.06%
Sep 25-162.17%
Sep 25-188.04%
Sep 25-200.7%
Aug 25-196%
Aug 25-183.11%
Aug 25-197.74%
Aug 25-186.17%
Aug 25-219.13%
Jul 25-169.63%
Jul 25-193.79%
Jul 25-182.61%
Jul 25-212.79%
Jun 25-207.56%
Jun 25-202.04%
Jun 25-212.79%
Jun 25-212.2%
May 25-215.2%
May 25-191.83%
May 25-233.03%
May 25-221.48%
May 25-211.02%
Apr 25-237.4%
Apr 25-230.2%
Apr 25-220.19%
Apr 25-280.32%
Mar 25-256.64%
Mar 25-261.05%
Mar 25-258.39%
Mar 25-302.97%
Feb 25-245.1%
Feb 25-236.46%
Feb 25-223.16%
Feb 25-229.62%
Jan 25-270.14%
Jan 25-258.91%
Jan 25-251.45%
Jan 25-256.63%
Jan 25-238.4%
Dec 24-229.01%
Dec 24-227.82%
Dec 24-232.11%
Dec 24-205.9%
Nov 24-296.63%
Nov 24-327.74%
Nov 24-337.87%
Nov 24-327.74%
Nov 24-301.75%
Oct 24-282.28%
Oct 24-245.81%
Oct 24-258.9%
Oct 24-201.63%
Sep 24-168.61%
Sep 24-292.67%
Sep 24-287.85%
Sep 24-311.45%
Aug 24-269.32%
Aug 24-246.15%
Aug 24-255.78%
Aug 24-281.75%
Aug 24-254.35%
Price to Sales
0500100015002000med 342.57May 24Sep 24Dec 24Aug 25Nov 25Mar 26Jun 26
HSCS Price to Sales by year
PeriodPrice to Sales
Jun 261787.16
Jun 26671.19
Jun 26656.6
Jun 26707.67
May 26609.18
May 26722.26
May 26660.25
May 26704.02
May 26725.91
Apr 26747.79
Apr 26784.27
Apr 26758.74
Apr 26838.99
Mar 26820.75
Mar 26930.18
Mar 26824.3
Mar 26846.75
Feb 26894.86
Feb 26901.28
Feb 26962.22
Feb 26959.01
Jan 261035.99
Jan 261106.55
Jan 261026.37
Jan 261052.03
Jan 261007.12
Dec 25914.11
Dec 25756.95
Dec 25531.84
Dec 25556.87
Nov 25558.95
Nov 25492.21
Nov 25640.29
Nov 25544.35
Oct 25636.12
Oct 25686.18
Oct 25694.52
Oct 25727.89
Oct 25771.69
Sep 25761.26
Sep 25727.89
Sep 25627.78
Sep 25852.54
Aug 25873.02
Aug 25934.46
Aug 25865.34
Aug 25919.1
Aug 25780.85
Jul 251008.71
Mar 25179.74
Feb 25222.18
Feb 25230.3
Feb 25244.03
Feb 25237.16
Jan 25201.59
Jan 25210.33
Jan 25216.57
Jan 25212.2
Jan 25228.43
Dec 24237.79
Dec 24239.03
Dec 24157.64
Dec 24177.71
Nov 24123.35
Nov 24111.64
Nov 24108.3
Nov 24111.64
Nov 24121.26
Oct 24129.62
Oct 24148.86
Oct 24141.33
Oct 24181.47
Sep 24217.02
Sep 24125.02
Sep 24127.12
Sep 24106.95
Aug 24123.68
Aug 24135.32
Aug 24130.23
Aug 24118.22
Aug 24130.95
Jul 24132.46
Jul 24105.27
Jul 24117.42
Jul 24127.54
Jun 24150.68
Jun 24151.83
Jun 24155.59
Jun 24168.61
May 24159.06
May 24179.31
May 24201.58
May 24254.5
May 24256.82
Apr 24281.69
Apr 24289.5
Apr 24309.45
Apr 24316.97
Mar 24338.08
Mar 24347.05
Price to Book
0102030med 1.61Sep 24Jan 25Apr 25Aug 25Nov 25Mar 26Jun 26
HSCS Price to Book by year
PeriodPrice to Book
Jun 262.19
Jun 262.15
Jun 262.31
May 261.99
May 262.36
May 262.16
May 262.3
May 262.37
Apr 262.44
Apr 262.56
Apr 262.48
Apr 262.74
Mar 262.68
Mar 263.04
Mar 261.71
Mar 261.76
Feb 261.85
Feb 261.87
Feb 261.99
Feb 261.99
Jan 262.15
Jan 262.29
Jan 262.13
Jan 262.18
Jan 262.09
Dec 251.89
Dec 251.57
Dec 251.06
Dec 251.11
Nov 251.11
Nov 250.98
Nov 251.27
Nov 251.08
Oct 251.27
Oct 251.37
Oct 251.38
Oct 251.45
Oct 251.54
Sep 251.51
Sep 251.45
Sep 251.25
Sep 2518.08
Aug 2518.51
Aug 2519.81
Aug 2518.35
Aug 2519.49
Aug 2516.56
Jul 2521.39
Jul 252.16
Jul 252.3
Jul 251.97
Jun 252.02
Jun 252.08
Jun 251.97
Jun 251.98
May 251.95
May 252.19
May 251.8
May 251.89
May 251.99
Apr 251.77
Apr 251.82
Apr 251.9
Apr 251.5
Mar 251.63
Mar 251.61
Mar 251.62
Mar 250.66
Feb 250.81
Feb 250.84
Feb 250.89
Feb 250.87
Jan 250.74
Jan 250.77
Jan 250.79
Jan 250.78
Jan 250.84
Dec 240.87
Dec 240.87
Dec 240.49
Dec 240.56
Nov 240.39
Nov 240.35
Nov 240.34
Nov 240.35
Nov 240.38
Oct 240.41
Oct 240.47
Oct 240.44
Oct 240.57
Sep 240.68
Sep 240.39
Sep 240.4
Sep 240.27
Aug 240.31
Aug 240.34
Aug 240.33
Aug 240.3
Aug 240.33
Jul 240.29
HeartSciences Inc.
HSCS
Stockpicker

Video analysis: HSCS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HSCS

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

globenewswire.com · 19 Aug 2026

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase date The exchange ratio under the merger agreement with Fortitude is unchanged, and no additional shares will be issued to holders of Fortitude's equity interests at closing as a result of the investment Following the investment, Fortitude holds approximately 9.4% of HeartSciences' outstanding shares of common stock Southlake, TX, Aug. 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that on August 12, 2026 Fortitude Mining Holdings, Inc. (“Fortitude”) purchased 411,522 shares of HeartSciences' common stock for an aggregate purchase price of approximately $1,000,000 in a private placement (the “Investment”). The shares were issued at a negotiated price of $2.43 per share, representing a 22% premium to the closing price of HeartSciences' common stock on the purchase date.

Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem

gurufocus.com · 30 Jul 2026

Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem

Fortitude Mining Holdings, Inc. ("Fortitude" or the “Company”), a vertically-integrated digital asset mining platform anchored in Zcash today announced it h

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

globenewswire.com · 29 Jul 2026

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch of the MyoVista Insights platform and submission of the MyoVista wavECG device to the FDA for 510(k) clearance

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

globenewswire.com · 23 Jul 2026

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be filed shortly, with fiscal 2026 earnings release and business update to follow Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be filed shortly, with fiscal 2026 earnings release and business update to follow

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

businesswire.com · 23 Jun 2026

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences”), an AI-powered medical technology company, today announced that they have entered into a definitive merger agreement to combine in an all-stock transaction (the “Proposed Transaction”) which is expected to close in H2 2026. Upon closing, the combined company will operate under the Fortitud.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.